Dr. Sezer Saglam

About Dr. Sezer Saglam

Dr. Sezer Sağlam has forged an illustrious career path in internal medicine and oncology, marked by extensive training and significant professional achievements.
His journey began in 1991 with medical training at Ege University, followed by completing his Internal Medicine specialty at Cerrahpaşa Medical Faculty in 1996.
In 1999, Dr. Sağlam expanded his expertise through a pivotal role at the American Cancer Center of Florence Nightingale Metropolitan Hospital, where he gained valuable experience in oncological care.
His commitment to advancing in the field led him to achieve specialization in Medical Oncology at Istanbul University Oncology Institute in 2005, solidifying his credentials in cancer management and treatment.
Dr. Sağlam has demonstrated unwavering dedication to patient care and medical advancement throughout his career, evident in his diverse educational background and substantial contributions to internal medicine and oncology.

Conditions treated by Dr. Sezer Sağlam

Breast Cancer and Gynecological Cancer
Melanoma, Brain Cancer
Soft tissue and Bone sarcomas
Hematological Malignancies such as lymphomas, leukemias, multiple myelomas
Gastrointestinal Cancer
Ewing Sarcoma

Area of Interest

Medical Oncology
Gastrointestinal Cancers
Gastric cancer
Ewing Sarcoma
Internal medicine

Qualification

2005- Istanbul University Oncology Institute
Medical Oncology Specialization Training
1999- American Cancer Center of Florence Nightingale Metropolitan Hospital
1997-1998: Bayraktar Dialysis Center
1996- Cerrahpaşa Medical Faculty
Internal Medicine Specialization Training
1991- Ege University
Medical Training

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

MEMBERSHIPS (3)

Medical Oncology Association
European Neuroendocrine Tumor Society (ENETS)
American Society of Clinical Oncology (ASCO)

RESEARCH PAPERS AND PUBLICATIONS (10)

Topuz E, Eralp Y, Saglam S, Saip P, Aydiner A, Berkman S, Yavuz E. Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer. Consolidative intraperitoneal cisplatin in ovarian cancer.Gynecol Oncol. 92(1): 147–5, 2004.
Balci NC, Akun E, Erturk M, Saglam S, Inan N, Balci Y. Renal-related perinephric fluid collections: MRI findings. Magn Resonance Imaging. 23(5): 679–84, 2005.
Basaran M, Bavbek ES, Saglam S, Eralp L, Sakar B, Atalar AC, Bilgic B, Ozger H, Onat H. A phase II study of cisplatin, ifosfamide, and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas. Oncology. 72(3–4): 255–60, 2007.
Sakar B, Gumus M, Basaran M, Argon A, Ustuner Z, Ustaoglu MA, Saglam S, Guney N, Tenekeci AN, Aykan NF. XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer. Oncology. 73(5–6): 298–304, 2007.
Topuz E, Derin D, Can G, Kürklü E, Cinar S, Aykan F, Cevikbaş A, Dışçi R, Durna Z, Sakar B, Saglam S, Tanyeri H, Deniz G, Gürer U, Taş F, Güney N, Aydiner A. Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Invest New Drugs. 26(6): 567–72, 2008.
Balci NC, Befeler AS, Bieneman BK, Fattahi R, Saglam S, Havlioglu N. Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging. Acad Radiol. 16(8): 963–8, 2009.
Balci NC, Perman WH, Saglam S, Akisik F, Fattahi R, Bilgin M. Diffusion-weighted magnetic resonance imaging of the pancreas. Top Magn Reson Imaging. 20(1): 43–7, 2009.
Saglam S, Suzme R, Gurdol F. Serum tumor necrosis factor-alpha and interleukin-2 concentrations in newly diagnosed ERBB2 (HER2/neu) positive breast cancer patients. Int J Biol Markers. 24(3): 142–6, 2009.
Saglam S, Aykan NF, Şakar B, et al. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma. Journal of Gastrointestinal Oncology.2; 219-26, 2011. Prof. Sezer Saglam, M.D.
Effects of surgical laparoscopic experience on the short-term postoperative outcome of rectal cancer: results of a high volume single center institution.Balik E, Asoglu O, Saglam S, Yamaner S, Akyuz A, Buyukuncu Y, Gulluoglu M, Bulut T , Bugra D. Surg Laparosc Endosc Percutan Tech. 2010;20:93-9.

Share Your Experience about Dr. Sezer Saglam

Write Your Review

PROCEDURES

Adrenal Cancer Treatment
Intensity-modulated radiotherapy (IMRT)
Malignant Mesothelioma Treatment
Nasopharyngeal Cancer Treatment
Papillary Thyroid Cancer Treatment
Penile Cancer Treatment
Rhabdomyosarcoma (RMS) Treatment
Robotic Cancer Surgery
Small Intestine Cancer Treatment
Thymectomy

FREQUENTLY ASKED QUESTIONS

Q: Is Doctor Sezer Saglam doing teleconsultation on the MediGence platform?

A. Dr. Sezer Saglam is available to teleconsultate on the MediGence platform.

Q: How long is the consultation?

A. The consultation can last up to 15 to 30 minutes. It may go beyond the estimated time which is dependent on the patient’s queries and the medical suggestions of the doctor.

Q: How soon can the consultation be organized?

A. We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organized within 24 to 48 hours or based on the availability of the doctor and the patient.

Q: Is follow-up consultation included in the consultation price?

A. No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

Q: How do I share my medical record with the doctor for review?

A. The option to share your medical records is available between the steps of the form provided to you on the website.

Q: Can I book my procedure with the doctor post-consultation?

A. Yes. If you are satisfied with the consultation, then you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Q: Is it possible to get the estimate for the procedure?

A. Yes. The cost estimate will be provided to you by our case manager including the doctor’s opinion, the cost estimate, and the crucial information about traveling to your medical destination.

Welcome To MediGence

Your Notifications